Reddy-Dasatinib 80 mg (Dasatinib (Dasatinib (S)-Propylene Glycol) TABLET) 80 MG

REDDY-DASATINIB 80 MG is a medication used to manage certain types of cancer. This oral tablet contains dasatinib, a tyrosine kinase inhibitor, and is manufactured by Dr. Reddy's Laboratories Ltd. in India.

Strength

80 MG

Manufacturer / TM Owner

DR REDDY'S LABORATORIES LTD

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

REDDY-DASATINIB 80 MG is primarily used in the treatment of specific types of leukemia and other cancers. Dasatinib works by targeting and inhibiting certain proteins that contribute to the growth of cancer cells. This medication is often prescribed for patients who have not responded to other treatments or have certain genetic markers that make them suitable for dasatinib therapy.

Side Effects

Common effects of REDDY-DASATINIB 80 MG may include fatigue, nausea, and skin rashes. Some users might experience more severe side effects, such as low blood cell counts or fluid retention. It is important to monitor for any unusual symptoms and consult a healthcare provider if significant side effects occur.

Precautions & Warnings

REDDY-DASATINIB 80 MG should be handled with care and stored as directed. It is essential to follow the prescribed dosage and administration instructions provided by a healthcare professional. Patients should inform their healthcare provider about any pre-existing conditions or other medications they are taking to avoid potential complications.

Avoid Interactions

REDDY-DASATINIB 80 MG may interact with certain medications, including those that affect liver enzymes or other cancer treatments. Consuming alcohol while taking this medication should be avoided, as it may increase the risk of side effects. Always consult a healthcare provider before starting or stopping any medication while on dasatinib therapy.

Frequently Asked Questions

REDDY-DASATINIB 80 MG is used to treat certain types of leukemia and other cancers by targeting specific proteins involved in cancer cell growth.

REDDY-DASATINIB 80 MG is an oral tablet that should be taken exactly as prescribed by a healthcare provider, typically with or without food.

Common side effects may include fatigue, nausea, skin rashes, and fluid retention. Severe side effects are less common but should be reported to a healthcare provider.

REDDY-DASATINIB 80 MG may interact with other medications, so it is important to consult a healthcare provider before combining it with any other treatments.

Consuming alcohol while taking REDDY-DASATINIB 80 MG is not recommended, as it may increase the risk of side effects.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.